Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.
Clinical trial NCT03545815 · UNKNOWN
Trial details
- NCT number
- NCT03545815
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-19
- Primary completion
- 2020-10-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.